Drooid Logo
Back to story perspectives

Full Breakdown

Concerns Surround AI Health Gadgets at CES 2026

1/8/2026, 11:28:55 AM

Promises and Pitfalls of Health Tech Innovations

At the 2026 Consumer Electronics Show (CES) in Las Vegas, a variety of health tech gadgets were showcased, including a smart scale that tracks heart health and an egg-shaped hormone tracker designed to assist with conception timing. However, experts in technology and health have raised concerns regarding the accuracy of these products and potential data privacy issues, particularly as the U.S. federal government relaxes regulations on health-related technologies. The Food and Drug Administration (FDA) announced it would ease regulations on "low-risk" wellness products, a move aligned with the Trump administration's broader strategy to foster AI innovation by removing regulatory barriers.

The Role of AI in Healthcare

AI technologies are increasingly recognized for their potential benefits within the $4.3 trillion healthcare industry. Marschall Runge, a professor of medical science at the University of Michigan, noted that AI can enhance medical imaging analysis and help manage the demanding schedules of healthcare professionals. Nonetheless, he cautioned that these technologies may also introduce biases and produce misleading information, a phenomenon often referred to as "hallucination."

Privacy Concerns and Consumer Trust

Cindy Cohn, executive director of the Electronic Frontier Foundation, emphasized the lack of privacy protections for data collected by consumer health devices, which are not covered by the Health Insurance Portability and Accountability Act (HIPAA). She highlighted the difficulty consumers face in understanding how their data is used, stating, “You have to dig down through the fine print to try to figure that out, and I just don’t think that’s fair or right for the people who might rely on it.”

Innovations Targeting Women's Health

Several products at CES focused on women's health, an area historically underfunded and under-researched. Sylvia Kang, founder and CEO of Mira, developed a hormone tracker to address the lack of knowledge surrounding hormonal health among women trying to conceive. Kang asserted that her product, which analyzes hormone data, does not share information with third parties. Similarly, Amy Divaraniya, founder of Oova, discussed the need for more research on menopause, highlighting a wearable device called Peri that monitors symptoms associated with perimenopause.

Enhancing Accessibility to Healthcare

Other innovations aimed to improve healthcare accessibility, particularly in underserved areas. The AI chatbot 0xmd, created by Allen Au, offers a free resource for medical inquiries, allowing users to upload images and receive simplified explanations of their medical notes. Au noted that while such tools can provide valuable second opinions, they are not intended to replace healthcare professionals.

Expert Skepticism

Despite the potential benefits of these technologies, experts like Cindy Cohn remain skeptical. She reiterated that while AI tools can assist users in formulating questions for their doctors, they should not be viewed as definitive sources of medical truth. “People need to remember that these are just tools; they’re not oracles who are delivering truths,” Cohn stated.

Conclusion

As health tech gadgets gain traction at events like CES, the balance between innovation and consumer protection remains a critical concern. While these technologies promise to enhance healthcare access and understanding, the implications for data privacy and accuracy warrant careful consideration from both consumers and regulators.